Received Mar 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | b0001 | IM / LA |
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | N/A | 79ky5 | IM / LA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | y008119 | IM / LA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | 1 | u8361aa | IM / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | m7yy5 | IM / RA |
Patient was administered Moderna covid vaccine for ages 12+ . Patient should have had Moderna covid vaccine for 6 months to 11 years. Patient and family were educated on vaccine, potential side effects, and adverse effects to be aware of and monitor. Talked with mother of patient who states that patient only has a sore arm. no other side effects or concerns at this time. Primary care provider was updated along with supervising staff per protocol. Manufacturer updated and discussed potential side effects. Dose will not be readministered. No change in treatment for this patient.
none
ADHD, Autism, tongue anomaly, congenital, speech articulation disorder
strattera, Multivitamin, zoloft
seasonal
non indicated at this time per PCP.